Quarterly report pursuant to Section 13 or 15(d)

Debt - Narrative (Details)

v3.10.0.1
Debt - Narrative (Details)
1 Months Ended 3 Months Ended 6 Months Ended 48 Months Ended
Jan. 30, 2013
USD ($)
d
$ / shares
Feb. 28, 2018
USD ($)
$ / shares
Nov. 30, 2015
USD ($)
Apr. 30, 2015
d
conversion_right
$ / shares
Jun. 30, 2018
USD ($)
institution
Jun. 30, 2017
USD ($)
Jun. 30, 2018
USD ($)
institution
Jun. 30, 2017
USD ($)
Dec. 31, 2016
USD ($)
shares
Dec. 31, 2017
USD ($)
institution
Debt Instrument [Line Items]                    
Change in FV of embedded derivative income         $ 0 $ 5,069,000 $ 0 $ 10,014,000    
Credit line capacity         196,900,000   196,900,000      
Goodwill         $ 714,234,000   $ 714,234,000     $ 717,099,000
Number of financial institutions | institution         11   11     11
BioReference                    
Debt Instrument [Line Items]                    
Net assets         $ 1,000,000,000   $ 1,000,000,000      
Goodwill         401,800,000   401,800,000      
Intangible assets         $ 425,400,000   $ 425,400,000      
OPKO Health Europe                    
Debt Instrument [Line Items]                    
Weighted average interest rate         3.00%   3.00%     3.00%
Minimum | OPKO Health Europe                    
Debt Instrument [Line Items]                    
Variable interest rates         1.80%   1.80%      
Maximum | OPKO Health Europe                    
Debt Instrument [Line Items]                    
Variable interest rates         6.30%   6.30%      
Senior Notes | Notes Due February 1, 2033                    
Debt Instrument [Line Items]                    
Interest rate on notes payable 3.00%                  
Debt face amount $ 175,000,000.0                  
Equivalent redemption price 100.00%                  
Notes | Notes Due February 1, 2033                    
Debt Instrument [Line Items]                    
Conversion price per share (in dollars per share) | $ / shares $ 7.07     $ 7.07            
Conversion rate 0.14148     0.1414827            
Equivalent redemption price 100.00%                  
Convertible debt, threshold percentage of stock price trigger 130.00%     130.00%            
Number of trading days | d       20            
Number of consecutive trading days applicable conversion price | d       30            
Common stock trigger price (in dollars per share) | $ / shares       $ 9.19            
Conversion right triggered | conversion_right       1            
Notes | Notes Due February 1, 2033 | Minimum                    
Debt Instrument [Line Items]                    
Number of trading days | d 20                  
Notes | Notes Due February 1, 2033 | Maximum                    
Debt Instrument [Line Items]                    
Number of consecutive trading days applicable conversion price | d 30                  
Notes | Notes Due February 1, 2033 | On or after February 1, 2017 and before February 1, 2019                    
Debt Instrument [Line Items]                    
Equivalent redemption price 100.00%                  
Notes | Notes Due February 1, 2033 | On or after February 1, 2019                    
Debt Instrument [Line Items]                    
Equivalent redemption price 100.00%                  
Convertible Debt | 5% Convertible Notes                    
Debt Instrument [Line Items]                    
Interest rate on notes payable   5.00%                
Debt face amount   $ 55,000,000.0                
Maturity duration   5 years                
Par value per converted share (in dollars per share) | $ / shares   $ 0.01                
Conversion price per share (in dollars per share) | $ / shares   $ 5.00                
Minimum conversion notice   30 days                
Maximum conversion notice   60 days                
Convertible Debt | Notes Due February 1, 2033                    
Debt Instrument [Line Items]                    
Converted debt amount                 $ 143,200,000.0  
Line of Credit                    
Debt Instrument [Line Items]                    
Weighted average interest rate         4.70%   4.70%     4.20%
Revolving Credit Facility | Line of Credit | New Credit Agreement                    
Debt Instrument [Line Items]                    
Credit line capacity     $ 175,000,000.0              
Higher borrowing capacity option     $ 275,000,000.0              
Remaining borrowing capacity         $ 0   $ 0      
Commitment fee percentage     0.50%              
Swingline | Line of Credit | New Credit Agreement                    
Debt Instrument [Line Items]                    
Credit line capacity     $ 20,000,000.0              
Letter of Credit | Line of Credit | New Credit Agreement                    
Debt Instrument [Line Items]                    
Credit line capacity     $ 20,000,000.0              
LIBOR | Revolving Credit Facility | Line of Credit | New Credit Agreement                    
Debt Instrument [Line Items]                    
Basis spread on variable rate     2.50%              
LIBOR, First 12 Months | Revolving Credit Facility | Line of Credit | New Credit Agreement                    
Debt Instrument [Line Items]                    
Basis spread on variable rate     0.35%              
LIBOR Thereafter | Revolving Credit Facility | Line of Credit | New Credit Agreement                    
Debt Instrument [Line Items]                    
Basis spread on variable rate     0.50%              
LIBOR, First 12 Months, Adjusted for Eurocurrency Liabilities | Revolving Credit Facility | Line of Credit | New Credit Agreement                    
Debt Instrument [Line Items]                    
Basis spread on variable rate     1.35%              
LIBOR, Thereafter, Adjusted for Eurocurrency Liabilities | Revolving Credit Facility | Line of Credit | New Credit Agreement                    
Debt Instrument [Line Items]                    
Basis spread on variable rate     1.50%              
Common Stock | Convertible Debt | Notes Due February 1, 2033                    
Debt Instrument [Line Items]                    
Shares issued on converted debt (in shares) | shares                 21,539,873